Tofacitinib Ameliorates Retinal Vascular Leakage in a Murine Model of Diabetic Retinopathy with Type 2 Diabetes
We have previously reported that inhibition of the Janus kinase 1 (JAK1) signaling ameliorates IL-17A-mediated blood-retinal barrier (BRB) dysfunction. Higher levels of IL-17A have been observed in the blood and intraocular fluids in patients with diabetic retinopathy (DR), in particular those with...
Enregistré dans:
Auteurs principaux: | Eimear M. Byrne, María Llorián-Salvador, Timothy J. Lyons, Mei Chen, Heping Xu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/87449f3a925a48d2b1438066aeb4b0e7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Edaravone alleviates cell apoptosis and mitochondrial injury in ischemia-reperfusion-induced kidney injury via the JAK/STAT pathway
par: Zhao,Xiaoying, et autres
Publié: (2020) -
Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review
par: Fei Qi, et autres
Publié: (2021) -
JQ-1 ameliorates schistosomiasis liver fibrosis by suppressing JAK2 and STAT3 activation
par: Han Ding, et autres
Publié: (2021) -
Corrigendum: ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway
par: Yu-Li Shen, et autres
Publié: (2021) -
CXCL8(3-72) K11R/G31P protects against sepsis-induced acute kidney injury via NF-κB and JAK2/STAT3 pathway
par: Zhou,Yunfeng, et autres
Publié: (2019)